Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Evidence for a higher resolution of HLA genotyping by a new NGS-based approach.

Alizadeh M, Walencik A, Frassati C, Moskovtchenko P, Lafarge X, Verite F, Semana G.

Transfus Clin Biol. 2017 Sep;24(3):120-123. doi: 10.1016/j.tracli.2017.05.011. Epub 2017 Jun 17. Review.

PMID:
28629606
2.

Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients.

Le Berre L, Rousse J, Gourraud PA, Imbert-Marcille BM, Salama A, Evanno G, Semana G, Nicot A, Dugast E, Guérif P, Adjaoud C, Freour T, Brouard S, Agbalika F, Marignier R, Brassat D, Laplaud DA, Drouet E, Van Pesch V, Soulillou JP.

Clin Immunol. 2017 Jul;180:128-135. doi: 10.1016/j.clim.2017.05.006. Epub 2017 May 18.

3.

Characterization of a new human monoclonal antibody directed against the Vel antigen.

Danger Y, Danard S, Gringoire V, Peyrard T, Riou P, Semana G, Vérité F.

Vox Sang. 2016 Feb;110(2):172-8. doi: 10.1111/vox.12321. Epub 2015 Sep 18.

PMID:
26382919
4.

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.

Pochon C, Oger E, Michel G, Dalle JH, Salmon A, Nelken B, Bertrand Y, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rohrlich P, Paillard C, Demeocq F, Schneider P, Plantaz D, Poirée M, Eliaou JF, Semana G, Drunat S, Jonveaux P, Bordigoni P, Gandemer V.

Br J Haematol. 2015 Apr;169(2):249-61. doi: 10.1111/bjh.13272. Epub 2014 Dec 19.

PMID:
25522886
5.

[Organization for the coverage of the transfusional needs of patients with hemoglobinopathy at the Établissement français du sang Bretagne].

Thibert JB, Danic B, Delamaire M, Delugin L, Dugor C, Le Vacon F, Nimubona S, Treussard D, Vasse J, Semana G.

Transfus Clin Biol. 2015 Mar;22(1):5-11. doi: 10.1016/j.tracli.2014.09.003. Epub 2014 Nov 6. French.

PMID:
25441455
6.

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.

Rossille D, Gressier M, Damotte D, Maucort-Boulch D, Pangault C, Semana G, Le Gouill S, Haioun C, Tarte K, Lamy T, Milpied N, Fest T; Groupe Ouest-Est des Leucémies et Autres Maladies du Sang; Groupe Ouest-Est des Leucémies et Autres Maladies du Sang.

Leukemia. 2014 Dec;28(12):2367-75. doi: 10.1038/leu.2014.137. Epub 2014 Apr 15.

PMID:
24732592
7.

Evaluation of CytoDiff™ on cord blood WBC differential.

Gac F, Thibert JB, Le Berre C, Le Priol J, Semana G, Fest T, Roussel M.

Int J Lab Hematol. 2013 Feb;35(1):46-54. doi: 10.1111/j.1751-553X.2012.01460.x. Epub 2012 Aug 2.

PMID:
22862853
8.

Measures to prevent transfusion-related acute lung injury (TRALI).

Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sánchez-Guerrero SA, Baptista-González HA, Martínez-Murillo C, Guerra-Márquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muñiz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S.

Vox Sang. 2012 Oct;103(3):231-59. doi: 10.1111/j.1423-0410.2012.01596.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519920
9.

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

Amé-Thomas P, Le Priol J, Yssel H, Caron G, Pangault C, Jean R, Martin N, Marafioti T, Gaulard P, Lamy T, Fest T, Semana G, Tarte K.

Leukemia. 2012 May;26(5):1053-63. doi: 10.1038/leu.2011.301. Epub 2011 Oct 21.

10.

Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.

Noël G, Brinster C, Semana G, Bruniquel D.

Int Immunol. 2009 Sep;21(9):1025-36. doi: 10.1093/intimm/dxp068. Epub 2009 Jul 22.

PMID:
19625380
11.

[Platelet transfusion: products, indications, dose, threshold and efficacy].

Andreu G, Vasse J, Tardivel R, Semana G.

Transfus Clin Biol. 2009 May;16(2):118-33. doi: 10.1016/j.tracli.2009.04.001. Epub 2009 May 13. Review. French.

PMID:
19443257
12.

Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells.

Noël G, Bruniquel D, Birebent B, DeGuibert S, Grosset JM, Bernard M, Dauriac C, Chevallier P, Lamy-de-la-Chapelle T, Semana G, Brinster C.

Clin Immunol. 2008 Nov;129(2):241-8. doi: 10.1016/j.clim.2008.07.019. Epub 2008 Aug 29.

PMID:
18760679
13.

HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.

Cournu-Rebeix I, Génin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D, Clerget-Darpoux F, Yaouanq J, Edan G, Rosenheim M, Fontaine B.

Genes Immun. 2008 Sep;9(6):570-4. doi: 10.1038/gene.2008.52. Epub 2008 Jul 10.

PMID:
18615093
14.

CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G, Lamy T, Fest T, Tarte K, Guillaudeux T.

J Immunol. 2008 Jul 15;181(2):1001-11.

15.

Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.

Noël G, Bruniquel D, DeGuibert S, Birebent B, Grosset JM, Bernard M, Dauriac C, Lamy-de-la-Chapelle T, Semana G, Brinster C.

Hum Immunol. 2008 Jun;69(6):329-37. doi: 10.1016/j.humimm.2008.04.008. Epub 2008 May 15.

PMID:
18571003
16.

Use of random versus apheresis platelet concentrates.

Andreu G, Vasse J, Sandid I, Tardivel R, Semana G.

Transfus Clin Biol. 2007 Dec;14(6):514-21. doi: 10.1016/j.tracli.2008.01.004. Epub 2008 Apr 15.

PMID:
18417401
17.

IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.

Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S, Müller-Sarnowski F, Uhr M, Bettecken T, Kohli M, Ripke S, Ising M, Rieckmann P, Brassat D, Semana G, Babron MC, Mrejen S, Gout C, Lyon-Caen O, Yaouanq J, Edan G, Clanet M, Holsboer F, Clerget-Darpoux F, Müller-Myhsok B.

Genes Immun. 2008 Apr;9(3):259-63. doi: 10.1038/gene.2008.14. Epub 2008 Mar 20.

PMID:
18354419
18.

Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.

Le Maux A, Noël G, Birebent B, Grosset JM, Vu N, De Guibert S, Bernard M, Semana G, Amiot L.

Clin Exp Immunol. 2008 Apr;152(1):50-6. doi: 10.1111/j.1365-2249.2008.03598.x. Epub 2008 Jan 28.

19.

[What's new in multiple sclerosis genetics?].

Fontaine B, Sémana G, Clerget-Darpoux F.

Rev Neurol (Paris). 2007 Jun;163(6-7):677-81. Review. French.

PMID:
17607189
20.

[Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients].

Andreu G, Vasse J, Hervé F, Tardivel R, Semana G.

Transfus Clin Biol. 2007 May;14(1):100-6. Epub 2007 May 23. French.

PMID:
17524696
21.

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.

Games Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J, Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K, Vécsei L, Heggarty S, Graham C, Hawkins S, Liguori M, Momigliano-Richiardi P, Caputo D, Grimaldi LM, Leone M, Massacesi L, Milanese C, Salvetti M, Savettieri G, Trojano M, Bielecki B, Mycko MP, Selmaj K, Santos M, Maciel P, Pereira C, Silva A, Silva BM, Coraddu F, Marrosu MG, Akesson E, Hillert J, Datta P, Oturai A, Harbo HF, Spurkland A, Goertsches R, Villoslada P, Eraksoy M, Hensiek A, Compston A, Setakis E, Gray J, Yeo TW, Sawcer S.

J Neuroimmunol. 2006 Oct;179(1-2):108-16. Epub 2006 Aug 24. Erratum in: J Neuroimmunol. 2007 Sep;189(1-2):175-6. multiple author names added.

PMID:
16934875
22.

A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility.

Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A, Lincoln RR, DeLoa C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, Oksenberg JR, Hafler DA.

Nat Genet. 2005 Oct;37(10):1113-8. Epub 2005 Sep 25.

23.

Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells.

Jugdé F, Boissier C, Rougier-Larzat N, Corlu A, Chesné C, Semana G, Heresbach D.

Toxicology. 2005 Sep 1;212(2-3):227-38.

PMID:
15961209
24.

A second-generation genomic screen for multiple sclerosis.

Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, Semana G, Cournu-Rebeix I, Lyon-Caen O, Fontaine B; American-French Multiple Sclerosis Genetics Group.

Am J Hum Genet. 2004 Dec;75(6):1070-8. Epub 2004 Oct 19.

25.

Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.

Birebent B, Lorho R, Lechartier H, de Guibert S, Alizadeh M, Vu N, Beauplet A, Robillard N, Semana G.

Eur J Immunol. 2004 Dec;34(12):3485-96.

26.

Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas.

Drénou B, Tilanus M, Semana G, Alizadeh M, Birebent B, Grosset JM, Dias P, van Wichen D, Arts Y, De Santis D, Fauchet R, Amiot L.

Br J Haematol. 2004 Oct;127(1):40-9.

PMID:
15384976
27.

NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.

Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J.

Eur J Gastroenterol Hepatol. 2004 Jan;16(1):55-62.

PMID:
15095853
28.

Stimulation of peripheral blood and intestinal mucosa cells by synthetic CpG oligodeoxynucleotides.

Jugdé F, Boissier C, Birebent B, Vu N, D'halluin PN, Rioux-Leclercq N, Bretagne JF, Semana G, Heresebach D.

Hum Immunol. 2004 Mar;65(3):218-30.

PMID:
15041160
29.

Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 alleles.

De Vreese K, Barylski R, Pughe F, Bläser M, Evans C, Norton J, Semana G, Holman R, Loiseau P, Masson D, Gielis M, De Brauwer A, De Canck I, Verpooten G, Hulstaert F.

Clin Diagn Lab Immunol. 2004 Mar;11(2):430-2.

30.

Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.

Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Cournu-Rebeix I, Azoulay-Cayla A, Lyon-Caen O, Fontaine B, Duhamel E, Coppin H, Brassat D, Roth MP, Clanet M, Alizadeh M, Yaouanq J, Quelvennec E, Semana G, Edan G, Babron MC, Genin E, Clerget-Darpoux F.

Neurogenetics. 2004 Feb;5(1):45-8. Epub 2003 Nov 1.

PMID:
14595552
31.

Genetic analysis of multiple sclerosis in Europeans: French data.

Alizadeh M, Génin E, Babron MC, Birebent B, Cournu-Rebeix I, Yaouanq J, Dréano S, Sawcer S, Compston A, Clanet M, Edan G, Fontaine B, Clerget-Darpoux F, Semana G; French Multiple Sclerosis Genetics Group.

J Neuroimmunol. 2003 Oct;143(1-2):74-8.

PMID:
14575918
32.

Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis.

Cournu-Rebeix I, Génin E, Lesca G, Azoulay-Cayla A, Tubridy N, Noé E, Clanet M, Edan G, Clerget-Darpoux F, Sémana G, Fontaine B.

Genes Immun. 2003 Oct;4(7):518-23.

PMID:
14551606
33.

Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.

Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, Fontaine B, Semana G.

Ann Neurol. 2003 Jul;54(1):119-22. Review.

PMID:
12838528
34.

Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.

Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G.

Tissue Antigens. 2003 Feb;61(2):166-71.

PMID:
12694585
35.

[Synopsis of the conferences F. Lhermitte. Immunomodulation and induction of tolerance in MS].

Semana G.

Rev Neurol (Paris). 2003 Feb;159(2):242-4. French. No abstract available.

PMID:
12660582
36.

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction.

Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, Lamy T, Le Prisé PY, Beauplet A, Bories D, Semana G, Quelvennec E.

Blood. 2002 Jun 15;99(12):4618-25.

37.

Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.

Jugde F, Alizadeh M, Boissier C, Chantry D, Siproudhis L, Corbinais S, Quelvennec E, Dyard F, Campion JP, Gosselin M, Bretagne JF, Sémana G, Heresbach D.

Eur Cytokine Netw. 2001 Jul-Sep;12(3):468-77.

38.

HLA class I and class II allele and haplotype diversity in Martinicans.

Bera O, Cesaire R, Quelvennec E, Quillivic F, de Chavigny V, Ribal C, Semana G.

Tissue Antigens. 2001 Mar;57(3):200-7.

PMID:
11285127
39.

Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.

Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, Semana G, Tiberghien P, Mercier P, Roudier J.

Arthritis Rheum. 2001 Mar;44(3):535-40.

40.

No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients.

Coppin H, Ribouchon MT, Bausero P, Pessac B, Fontaine B, Semana G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group.

Genes Immun. 2000 Dec;1(8):478-82.

41.

Analysis of TNFalpha microsatellites in 35 patients with primary Sjögren's syndrome.

Guggenbuhl P, Veillard E, Quelvenec E, Jego P, Semana G, Jean S, Meadeb J, Chalès G, Perdriger A.

Joint Bone Spine. 2000;67(4):290-5.

PMID:
10963076
42.

[Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].

Durand F, Danic B, Tardivel R, Semana G, Gouezec H, Martinot M, Marcellin P, Beauplet A.

Transfus Clin Biol. 2000 Jun;7(3):242-50. French.

PMID:
10919211
43.

[Frequency and prognostic value of epithelioid granuloma in inflammatory bowel disease].

Heresbach D, Heresbach-Le Berre N, Ramée MP, Sémana G, Gosselin M, Bretagne JF.

Gastroenterol Clin Biol. 1999 Dec;23(12):1376-87. Review. French. No abstract available.

44.

Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis.

Perdriger A, Guggenbuhl P, Chalès G, Yaouanq J, Quelvennec E, Bonnard MN, Pawlotsky Y, Semana G.

Rheumatology (Oxford). 1999 May;38(5):448-52.

PMID:
10371284
45.

Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.

Brassat D, Azais-Vuillemin C, Yaouanq J, Semana G, Reboul J, Cournu I, Mertens C, Edan G, Lyon-Caen O, Clanet M, Fontaine B.

Neurology. 1999 May 12;52(8):1632-6.

PMID:
10331690
46.

T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.

Semana G, Gausling R, Jackson RA, Hafler DA.

J Autoimmun. 1999 Jun;12(4):259-67.

PMID:
10330297
47.

Environmental factors may modulate antiphospholipid antibody production in family members of patients with systemic lupus erythematosus.

Saraux A, Jouquan J, Le Goff P, Youinou P, Levy Y, Piette JC, Guillevin L, Semana G, Salmon D, Viard JP, Bach JF, Shoenfeld Y.

Arthritis Rheum. 1999 May;42(5):1062-4. No abstract available.

48.

An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).

Heresbach D, Sémana G, Gosselin M, Bretagne MG.

Eur Cytokine Netw. 1999 Mar;10(1):7-15. Review.

49.

Pregnancy-associated autoimmune neonatal thrombocytopenia: role of maternal HLA genotype.

Gandemer V, Kaplan C, Quelvennec E, Poulain P, Laurent MC, Semana G, Renouard J, Le Gall E.

Br J Haematol. 1999 Mar;104(4):878-85.

PMID:
10192454
50.

DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.

Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G.

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):725-8.

PMID:
9844767

Supplemental Content

Loading ...
Support Center